Étude des délais de consultation, du diagnostic et du suivi des patients cancéreux à l’Hôpital PZAGA Mahajanga, Madagascar (notice n° 1369462)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04339cam a2200337 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250615090252.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Randrianarisoa, Rova Malala Fandresena |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Étude des délais de consultation, du diagnostic et du suivi des patients cancéreux à l’Hôpital PZAGA Mahajanga, Madagascar |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2025.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 33 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Introduction: Early or late diagnosis and treatment of cancer patients are key factors in their prognosis and survival. Measuring cancer management times and identifying the associated factors can help to optimize them. Our objective was to analyze medical management times for cancer patients in the oncology department of the PZAGA Hospital in Mahajanga. Patients and methods: This was a longitudinal study with retrospective cross-sectional data collection, including patients diagnosed with cancer who received specific treatment between January 2014 and December 2019. We examined all management times, from D1 (between initial symptoms and the first consultation) to D8 (between the first oncology consultation and the date of the most recent medical visit). Management times were reported in “day(s).” Results: 177 patients were included, with a mean age of 52.53±13.88 years and a sex ratio of 0.35. Breast cancer was the most common cancer (n=50). Chemotherapy (n=142) was the most common specific treatment. The mean D1 management time was 35.43 days, and the mean D8 management time was 304.25 days. There was a significant association between occupational activity and D1 (p=0.019) and D8 (p=0.001) management times, and between cancer site and D2 (p=0.030) and D7 (p=0.032) management times. Conclusion: Management times were long overall, and varied by cancer site and patient activity. Interventions should focus on these identified factors, pending further data. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Introduction : La précocité ou le retard de la prise en charge des patients atteints de cancer sont des éléments déterminants de leur pronostic et de leur survie. Mesurer les délais de prise en charge et identifier les facteurs associés permettent de les optimiser. Notre objectif était de rapporter les délais de prise en charge médicale des patients cancéreux dans le service d’oncologie de l’hôpital PZAGA Mahajanga. Patients et méthodes : Il s’agissait d’une étude longitudinale à collecte rétrospective transversale incluant les patients diagnostiqués de cancer et ayant reçu un traitement spécifique entre janvier 2014 et décembre 2019. Nous avons étudié tous les délais, de D1 (entre les premiers symptômes et la première consultation) à D8 (entre la première consultation oncologique et la date de dernières nouvelles). Les délais étaient présentés “en jour(s)”. Résultats : Cent soixante-dix-sept patients étaient retenus avec un âge moyen de 52,53 ± 13,88 ans et un sex-ratio de 0,35. Les cancers étaient essentiellement mammaires (n=50). La chimiothérapie (n=142) était le traitement spécifique le plus représenté. Le délai D1 moyen était de 35,43 jours et le délai D8 de 304,25 jours. Il y avait une association significative entre le domaine d’activité professionnelle et les délais D1 (p=0,019) et D8 (p=0,001), et entre la localisation du cancer et les délais D2 (p=0,030) et D7 (p=0,032). Conclusion : Les délais étaient globalement longs et variaient en fonction de la localisation du cancer et de l’activité du patient. Les interventions doivent être axées sur ces facteurs identifiés en l’attente de données complémentaires. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cancer |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | délais |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | diagnostic |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | traitement. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cancer |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | diagnosis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | management times |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | treatment. |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Refeno, Valéry |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ranaivoson, Mirana Andoniaina Christiana |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rabeoizy, Navarron Yourrustors |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Emile Hasiniatsy, Nomeharisoa Rodrigue |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tiandaza, Odilon Dinaraly |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rafaramino, Florine |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Santé Publique | 37 | 2 | 2025-05-26 | p. 159-166 | 0995-3914 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-sante-publique-2025-2-page-159?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-sante-publique-2025-2-page-159?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux